Why the study?
The earliest myocardial responses to sugar-driven metabolic overload and their modulation by plant-derived bioactive compounds such as full-spectrum cannabis oil remain incompletely understood.
Population
Male Wistar rats
Comparison
Reference diet vs sucrose-rich diet vs sucrose-rich diet plus oral full-spectrum cannabis oil (CBD:THC 2:1; 1 mg/kg/day)
Design
Preclinical animal study
Follow-up
3 weeks
Sucrose-rich diet raises blood pressure in rats; hypothesis-generating for cannabis oil cardioprotection, requiring human trials before any clinical consideration.
Introduction Excessive intake of added sugars promotes metabolic disease, but the earliest myocardial responses to sugar-driven metabolic overload and their modulation by plant-derived bioactive compounds remain incompletely understood. We investigated whether a short-term sucrose-rich diet induces early cardiac remodeling and whether a full-spectrum cannabis oil (CO) can prevent these alterations. Methods Male Wistar rats were assigned for 3 weeks to a reference diet, a sucrose-rich diet, or a sucrose-rich diet plus full-spectrum CO (cannabidiol [CBD]: tetrahydrocannabinol [THC] ratio 2:1; 1 mg/kg/day, orally). Results Throughout the study period, the sucrose-rich diet significantly increased systolic and diastolic blood pressure (group effect, p = 0.0003 and p = 0.0029, respectively) and circulating cardiac injury markers (creatine kinase-MB [CK-MB], p = 0.0048; lactate dehydrogenase [LDH], p = 0.0173), promoted myocardial triglyceride accumulation ( p = 0.0002), and altered lipid metabolism-related regulators (e.g., fatty acid synthase [FAS], p = 0.0002; sterol regulatory element-binding protein 1c [SREBP-1c], p = 0.0007). These changes were accompanied by oxidative stress (reactive oxygen species [ROS], p < 0.0001), impaired antioxidant defenses (catalase [CAT], p < 0.0001), inflammatory and endothelial activation (nuclear factor-κB [NF-κB], p = 0.0049; vascular cell adhesion molecule-1 [VCAM-1], p < 0.0001), early fibrotic remodeling (myocardial collagen content, p < 0.0001), histological and ultrastructural injury, and increased cardiac cannabinoid receptor type 1 (CB 1 R, p = 0.0001) and cannabinoid receptor type 2 (CB 2 R, p = 0.0003) protein expression, whereas electrocardiographic parameters (heart rate, PR interval, QRS complex, corrected QT interval [QTc]) remained unchanged (all p > 0.05). Discussion Cannabis oil administration prevented or markedly attenuated most of these alterations, including cardiac lipid accumulation, redox imbalance, inflammatory and remodeling-related signaling, structural damage, and cannabinoid receptor upregulation. These findings show that the myocardium is an early target of sucrose-driven metabolic overload and identify full-spectrum CO as a plant-derived bioactive intervention capable of limiting early cardiac metabolic and redox-inflammatory remodeling in this preclinical model. Further studies are required to define the contribution of individual phytocannabinoids and to determine whether cannabinoid receptor signaling contributes to these effects.
No takes yet. Share an insight, caveat, or question.
Degrave et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: